Prediabetes drug study pulled before it began
Disease control
Terminated
This study was designed to test whether metformin, a common diabetes drug, could improve blood vessel function in people with prediabetes. It planned to enroll adults aged 18-55 with prediabetes and compare metformin to a placebo over 12 weeks. However, the study was withdrawn be…
Phase: PHASE2 • Sponsor: Diana Jalal • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC